Fair Value Measurements (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Fair Value Disclosures [Abstract] |
|
Schedule of Fair Value of Financial Instruments Measured on a Recurring Basis |
The following tables present the financial instruments carried at fair value as of June 30, 2025 and December 31, 2024, by caption on the consolidated balance sheet and by FASB ASC 820 valuation hierarchy (as described above):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets and Liabilities Measured at Fair Value on a Recurring Basis |
|
|
|
(In Thousands) |
|
|
|
Total Carrying Value in the Consolidated Balance Sheet |
|
|
Quoted Market Prices in an Active Market (Level 1) |
|
|
Models with Significant Observable Market Parameters (Level 2) |
|
|
Models with Significant Unobservable Market Parameters (Level 3) |
|
June 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment securities available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury and other U.S. government agencies |
|
$ |
4,675 |
|
|
$ |
4,675 |
|
|
$ |
— |
|
|
$ |
— |
|
U.S. Government sponsored enterprises |
|
|
160,417 |
|
|
|
— |
|
|
|
160,417 |
|
|
|
— |
|
Mortgage-backed securities |
|
|
526,066 |
|
|
|
— |
|
|
|
526,066 |
|
|
|
— |
|
Asset-backed securities |
|
|
48,908 |
|
|
|
— |
|
|
|
48,908 |
|
|
|
— |
|
State and municipal securities |
|
|
153,627 |
|
|
|
— |
|
|
|
153,627 |
|
|
|
— |
|
Total investment securities available-for-sale |
|
|
893,693 |
|
|
|
4,675 |
|
|
|
889,018 |
|
|
|
— |
|
Mortgage loans held for sale |
|
|
5,094 |
|
|
|
— |
|
|
|
5,094 |
|
|
|
— |
|
Derivative instruments |
|
|
97 |
|
|
|
— |
|
|
|
97 |
|
|
|
— |
|
Other investments |
|
|
2,209 |
|
|
|
— |
|
|
|
— |
|
|
|
2,209 |
|
Total assets |
|
$ |
901,093 |
|
|
$ |
4,675 |
|
|
$ |
894,209 |
|
|
$ |
2,209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
|
35 |
|
|
|
— |
|
|
|
35 |
|
|
|
— |
|
Total liabilities |
|
$ |
35 |
|
|
$ |
— |
|
|
$ |
35 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
Investment securities available-for-sale: |
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury and other U.S. government agencies |
|
$ |
4,538 |
|
|
$ |
4,538 |
|
|
$ |
— |
|
|
$ |
— |
|
U.S. Government sponsored enterprises |
|
|
161,973 |
|
|
|
— |
|
|
|
161,973 |
|
|
|
— |
|
Mortgage-backed securities |
|
|
454,196 |
|
|
|
— |
|
|
|
454,196 |
|
|
|
— |
|
Asset-backed securities |
|
|
50,817 |
|
|
|
— |
|
|
|
50,817 |
|
|
|
— |
|
Corporate bonds |
|
|
2,396 |
|
|
|
— |
|
|
|
2,396 |
|
|
|
— |
|
State and municipal securities |
|
|
153,973 |
|
|
|
— |
|
|
|
153,973 |
|
|
|
— |
|
Total investment securities available-for-sale |
|
|
827,893 |
|
|
|
4,538 |
|
|
|
823,355 |
|
|
|
— |
|
Mortgage loans held for sale |
|
|
2,529 |
|
|
|
— |
|
|
|
2,529 |
|
|
|
— |
|
Derivative instruments |
|
|
61 |
|
|
|
— |
|
|
|
61 |
|
|
|
— |
|
Other investments |
|
|
2,191 |
|
|
|
— |
|
|
— |
|
|
|
2,191 |
|
Total assets |
|
$ |
832,674 |
|
|
$ |
4,538 |
|
|
$ |
825,945 |
|
|
$ |
2,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative instruments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total liabilities |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
Schedule of Fair Value of Financial Instruments Measured on a Non-recurring Basis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis |
|
|
|
(In Thousands) |
|
|
|
Total Carrying Value in the Consolidated Balance Sheet |
|
|
Quoted Market Prices in an Active Market (Level 1) |
|
|
Models with Significant Observable Market Parameters (Level 2) |
|
|
Models with Significant Unobservable Market Parameters (Level 3) |
|
June 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
Other real estate owned |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Collateral dependent loans (¹) |
|
|
4,275 |
|
|
|
— |
|
|
|
— |
|
|
|
4,275 |
|
Total |
|
$ |
4,275 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,275 |
|
December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
Other real estate owned |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Collateral dependent loans (¹) |
|
|
37,045 |
|
|
|
— |
|
|
|
— |
|
|
|
37,045 |
|
Total |
|
$ |
37,045 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
37,045 |
|
(1)The carrying value of collateral dependent loans at June 30, 2025 and December 31, 2024 is net of a valuation allowance of $418,000 and $408,000, respectively.
|
Schedule of Fair Value Assets Measured At Nonrecurring Basis |
The following table presents additional quantitative information about assets measured at fair value on a nonrecurring basis and for which we have utilized Level 3 inputs to determine fair value at June 30, 2025 and December 31, 2024:
|
|
|
|
|
|
|
|
|
Valuation Techniques (1) |
|
Significant Unobservable Inputs |
|
Weighted Average |
Collateral dependent loans |
|
Appraisal |
|
Estimated costs to sell |
|
10% |
Other real estate owned |
|
Appraisal |
|
Estimated costs to sell |
|
10% |
(1)The fair value is generally determined through independent appraisals of the underlying collateral, which may include Level 3 inputs that are not identifiable, or by using the discounted cash flow method if the loan is not collateral dependent.
|
Summary of Changes in Fair Value Due to Observable Factors |
The tables below includes a rollforward of the balance sheet amounts for the three and six months ended June 30, 2025 and 2024 (including the change in fair value) for financial instruments classified by the Company within Level 3 of the valuation hierarchy for assets and liabilities measured at fair value on a recurring basis.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
|
Other Assets |
|
|
Other Liabilities |
|
|
Other Assets |
|
|
Other Liabilities |
|
Fair value, April 1 |
|
$ |
2,207 |
|
|
|
— |
|
|
$ |
2,080 |
|
|
|
— |
|
Total realized gains included in income |
|
|
2 |
|
|
|
— |
|
|
|
21 |
|
|
|
— |
|
Change in unrealized gains/losses included in other comprehensive income for assets and liabilities still held at June 30 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Purchases, issuances and settlements, net |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfers out of Level 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Fair value, June 30 |
|
$ |
2,209 |
|
|
|
— |
|
|
$ |
2,101 |
|
|
|
— |
|
Total realized gains included in income related to financial assets and liabilities still on the consolidated balance sheet at June 30 |
|
$ |
2 |
|
|
|
— |
|
|
$ |
21 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
|
Other Assets |
|
|
Other Liabilities |
|
|
Other Assets |
|
|
Other Liabilities |
|
Fair value, January 1 |
|
$ |
2,191 |
|
|
|
— |
|
|
$ |
2,045 |
|
|
|
— |
|
Total realized gains included in income |
|
|
18 |
|
|
|
— |
|
|
|
56 |
|
|
|
— |
|
Change in unrealized gains/losses included in other comprehensive income for assets and liabilities still held at June 30 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Purchases, issuances and settlements, net |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfers out of Level 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Fair value, June 30 |
|
$ |
2,209 |
|
|
|
— |
|
|
$ |
2,101 |
|
|
|
— |
|
Total realized gains included in income related to financial assets and liabilities still on the consolidated balance sheet at June 30 |
|
$ |
18 |
|
|
|
— |
|
|
$ |
56 |
|
|
|
— |
|
|
Schedule of Carrying Value and Estimated Fair Value of Financial Instruments |
The following table presents the carrying amounts, estimated fair value and placement in the fair valuation hierarchy of the Company’s financial instruments at June 30, 2025 and December 31, 2024.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying/ Notional |
|
|
Estimated |
|
|
Quoted Market Prices in an Active Market |
|
|
Models with Significant Observable Market Parameters |
|
|
Models with Significant Unobservable Market Parameters |
|
(in Thousands) |
|
Amount |
|
|
Fair Value(¹) |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
June 30, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
245,313 |
|
|
|
245,313 |
|
|
|
245,313 |
|
|
|
— |
|
|
|
— |
|
Loans, net |
|
|
4,234,091 |
|
|
|
4,166,792 |
|
|
|
— |
|
|
|
— |
|
|
|
4,166,792 |
|
Mortgage servicing rights |
|
|
1,255 |
|
|
|
1,722 |
|
|
|
— |
|
|
|
1,722 |
|
|
|
— |
|
Financial liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits |
|
|
5,039,737 |
|
|
|
4,481,579 |
|
|
|
— |
|
|
|
— |
|
|
|
4,481,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
247,589 |
|
|
|
247,589 |
|
|
|
247,589 |
|
|
|
— |
|
|
|
— |
|
Loans, net |
|
|
4,042,392 |
|
|
|
3,986,187 |
|
|
|
— |
|
|
|
— |
|
|
|
3,986,187 |
|
Mortgage servicing rights |
|
|
1,139 |
|
|
|
1,654 |
|
|
|
— |
|
|
|
1,654 |
|
|
|
— |
|
Financial liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits |
|
|
4,830,034 |
|
|
|
4,253,072 |
|
|
|
— |
|
|
|
— |
|
|
|
4,253,072 |
|
(1)Estimated fair values are consistent with an exit-price concept. The assumptions used to estimate the fair values are intended to approximate those that a market-participant would realize in a hypothetical orderly transaction.
|